Abstract Background Diet and gut microbiota are pivotal in the pathogenesis of Crohn's disease (CD). DL-endopeptidases from Firmicutes can produce ligands for NOD2 receptors, facilitating the alleviation of intestinal inflammation. This study investigates how diet influences gut microbiota and intestinal inflammation, focusing on the correlation between dietary intake and the abundance of DL-endopeptidase genes, and explores potential dietary interventions. Methods Data were derived from the SOURCE cohort at the First Affiliated Hospital of Sun Yat-sen University, including 252 participants (47 CD patients and 205 healthy controls). Fecal metagenomic sequencing quantified three DL-endopeptidase subclasses: secreted NLPC_P60 (P60S), non-secreted NLPC_P60 (P60N), and peptidase M14 (M14). A Food Frequency Questionnaire (FFQ) assessed dietary intake across 27 nutrients. Correlations were analyzed between DL-endopeptidase gene abundance, CD clinical features, inflammatory markers, and nutrient intake. Results CD patients showed significantly lower abundance of all three DL-endopeptidase subclasses compared to healthy controls (P < 0.01). Among CD patients, M14 abundance was higher in remission compared to mild (P < 0.1) or moderate disease activity (P < 0.05). DL-endopeptidase abundance was not associated with disease location, behavior, upper gastrointestinal involvement, or perianal lesions (P > 0.05). Negative correlations were observed between DL-endopeptidase and inflammatory markers (WBC, platelets, ESR, CRP), while positive correlations emerged with remission markers (hemoglobin, albumin, vitamin D). Dietary analyses revealed negative correlations between M14 and fat, red meat, and iron intake in healthy controls (P < 0.05), with similar trends for P60S and P60N. In CD patients, P60N negatively correlated with total energy intake (P < 0.05), while vitamin B12 and vitamin D positively correlated with DL-endopeptidase abundance. Conclusion DL-endopeptidase abundance is linked to gut inflammation and dietary patterns in CD. Dietary interventions could potentially modulate DL-endopeptidase-producing Firmicutes bacteria to mitigate inflammation. Future studies aim to validate these findings in external cohorts and animal models, offering new insights into dietary strategies as adjunct therapies for CD. This work highlights the importance of the diet-microbiota-inflammation axis in understanding and managing CD progression and prognosis.
Read full abstract